Genprex

Monthly Archives: August 2016

Genprex Signs Capital Markets Advisory Agreement with Network 1 Financial as Part of an Overall Financing Plan

AUSTIN, TX, August 24, 2016 – Genprex, Inc. announced today that it has signed a capital markets advisory agreement with Network 1 Financial Securities, Inc. as a first step in the Company’s plan for funding its capital needs as it enters into advanced clinical trials for its lead drug candidate. Upon completion of the initial phase of this agreement, which is expected to occur well before the end of this year, the Company intends to put in place an overall plan with Network 1 Financial to provide for its immediate and long term capital needs and for the ultimate goal of being a public company….

Read More